Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. It operates in two segments, N...
KMB closed at $94.47, down 0.31%, as strong Q1 earnings and institutional buying interest were offset by continued pressure from the stock's pronounced underperformance. The company reported Q1 EPS of $2.00, up 17.93% year-over-year, with net profit rising 17.28% to $665 million on revenues of $4.16 billion, up 2.69%. Despite this earnings strength, KMB trades 32.71% below its 52-week high of $140.39 and just 2.22% above its 52-week low, reflecting the consumer staples sector's structural headwinds. The stock trades significantly below its 20-day and 60-day moving averages at $97.52 and $97.72 respectively. Institutional investors have remained active, with recent purchases from Norges Bank, Triodos Investment Management, and Allstate, while analyst coverage includes a buy rating with a $120 price target, implying 27% upside. The 5.36% dividend yield and 14.8x P/E valuation present potential appeal, though the stock's struggles suggest investors remain cautious on consumer staples cyclicality and competitive dynamics.
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026
KIMBER/A: Record revenue, strong profit growth, and robust innovation offset cost and pricing pressures
What to Expect From Kimberly-Clark's Next Quarterly Earnings Report
Inside the Fringe Tech Shakeup: Xanadu’s Quantum Push and SRM’s Crypto Pivot
Strategic Overhauls and M&A: Key Moves Beyond the Tech Spotlight
Prosperity Consulting Group LLC Sells 11,360 Shares of Kimberly-Clark Corporation $KMB